MICHAEL R DOUGHERTY Insider Trading $MLNT MELINTA THERAPEUTICS, INC. /NEW/

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MICHAEL R DOUGHERTY.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MICHAEL R DOUGHERTY. MICHAEL R DOUGHERTY is Director in Aviragen Therapeutics, Inc. ($NABI) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in MARINUS PHARMACEUTICALS INC ($MRNS) and Director in Celator Pharmaceuticals Inc ($CPXX) and Executive Chairman in Celator Pharmaceuticals Inc ($CPXX) and Director in TREVENA INC ($TRVN) and Director in CEMPRA, INC. ($CEMP) and Director in Foundation Medicine, Inc. ($FMI).

MICHAEL R DOUGHERTY in MELINTA THERAPEUTICS, INC. /NEW/

Trading Symbol: MLNT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL R DOUGHERTY: Director
Holdings: 2,000 shares
Current Value: $6,000
Latest Transaction: Jan 05 2017
$MLNT Market Capitalization: $151.90M
$MLNT Previous Close: $3.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of MICHAEL R DOUGHERTY in MELINTA THERAPEUTICS, INC. /NEW/

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CPXX, FMI, IDRA, MRNS, MLNT, TRVN, VXRT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 05 2017CEMPCEMPRA, INC.DOUGHERTY MICHAEL RDirectorOption ExerciseA3.0015,00045,00015,000
Jan 05 2016CEMPCEMPRA, INC.DOUGHERTY MICHAEL RDirectorOption ExerciseA31.1315,000466,95015,000
Oct 27 2015CEMPCEMPRA, INC.DOUGHERTY MICHAEL RDirectorBuyP18.452,00036,8962,0000 to 2 K

Page:   1